You are here

Article Text

Article menu
Download PDFPDF
Prevention
Systematic review with meta-analysis
Meta-analysing randomised controlled trials with omega-3 fatty acids in cardiovascular disease
  1. Clemens von Schacky
  1. Department of Preventive Cardiology, University of Munich, Munich, Germany
  1. Correspondence to : Clemens von Schacky
    Department of Preventive Cardiology, University of Munich, Ziemssenstr. 1 Munich 80336, Germany; Clemens.vonschacky{at}med.uni-muenchen.de

https://doi.org/10.1136/eb-2012-100960

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on Kwak SM, Myung SK, Lee YJ, et al.; for the Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomised, double-blind, placebo-controlled trials. Arch Intern Med 2012;172:686–94.OpenUrlCrossRefPubMedWeb of Science

    Context

    Systematic reviews and meta-analyses have yielded conflicting results regarding the efficacy of ω-3 fatty acids for preventing cardiovascular events or reducing mortality.1 A meta-analysis of randomised, double-blind, placebo-controlled trials now adds to the literature.

    Methods

    Medline and bibliographies of publications were searched with pertinent keywords, and publications were selected, if trial participants were >18 years of age, had a history of coronary artery disease, used omega-3 fatty acid supplements for >1 year; and if the study design was randomised, double-blind, placebo-controlled, and the trial reported major adverse events …

    View Full Text

    Footnotes

    • Competing interests None.